PPT2 and nonpapillary renal cell carcinoma: As shown in Figure 4A-B, the results of Western Blot and Quantitative Real-time PCR (qRT-PCR) revealed that PPT2 is downregulated in ccRCC tissues collected from clinical application at both mRNA and protein levels (Figure 4A-B).